Interferon
COVID-19: Autoantibodies can cause severe disease and deaths
Various studies have revealed that autoantibodies have been a key driver of severe illness and deaths amongst people critically infected with COVID-19. Findings also show that autoantibodies’ concentration in human bodies increases with age
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
- Google employees lead sit-ins protesting company’s complicity in genocide
- Israeli tourists attack vigil in Cusco in support of Palestine
- During Red April, Brazil’s MST restates the importance of agrarian reform
- German authorities’ crackdown on Palestine Conference sparks widespread outrage
- As elections approach, India’s farmers count government’s broken promises
